
Alto Neuroscience, a clinical-stage biopharmaceutical company specialising in precision treatments for neuropsychiatric conditions, has announced the issuance of a US …

EA Pharma, a subsidiary of Eisai, has announced the initiation of a phase 3 clinical trial of evenamide, a schizophrenia …

1 Rapid Eye Movement (REM) sleep enhances creative thinking and helps the brain form connections between ideas, supporting mental wellbeing …

According to new data published by the NHS Business Services Authority (NHSBSA), mental health prescriptions in England have reached their …

Seaport Therapeutics has dosed its first patient in its phase 2b BUOY-1 study of GlyphAllo (SPT-300), an oral prodrug of …

Otsuka and Click Therapeutics have launched Rejoyn, a prescription digital therapeutic for major depressive disorder (MDD), in the UK. The …

32% of people suffer from at least one mental health issue, with daily struggles like financial and job insecurity being …

Newron Pharmaceuticals has announced the approval for its ENIGMA-TRS phase 3 development programme evaluating evenamide as an add-on therapy to …

From prostate cancer to hormonal health, many areas of menโs health require more attention. As male life expectancy and healthy …

US RNA biomarker company Circular Genomics has announced study results highlighting the companyโs first blood assay to predict a patientโs …

Researchers from the University of Surrey, UK, and the Hebrew University of Jerusalem, Israel, have found that non-invasive brain stimulation …

Canadian biotechnology company PharmAla has announced that it has been awarded a research grant from the Ontario Centre of Innovation …